Janet Youkhana
University of New South Wales, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Suppression of the Cystine-Glutamate Transporter SLC7A11/xCT system enhances sensitivity of lung cancer cells to platinum-based drugs. (#124)
1:00 PM
Anya Jensen
Lunch & Poster Viewing (Even Numbers)
βIII-Tubulin knockdown sensitises pancreatic tumours to the tumour-specific death ligand TRAIL. (#37)
12:25 PM
George Sharbeen
Concurrent Session - Cancer Biology
Novel drug (CRO-67) in commercial pipeline have both anti-tumour and stromal reprogramming capacity (#108)
1:00 PM
Shannon Chiang
Lunch & Poster Viewing (Even Numbers)
SPEAR: A Phase 2, Open-label, Single-arm Monotherapy Trial of Sulfasalazine in Pancreatic Adenocarcinoma – Trial in Progress (#321)
12:45 PM
Omali Pitiyarachchi
Lunch & Poster Viewing (Odd Numbers)